# | Title | Journal | Year | Citations |
---|
1 | Obesity and cancer risk: Emerging biological mechanisms and perspectives | Metabolism: Clinical and Experimental | 2019 | 821 |
2 | Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York | Metabolism: Clinical and Experimental | 2020 | 682 |
3 | Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics | Metabolism: Clinical and Experimental | 2019 | 679 |
4 | Circulating irisin levels and coronary heart disease: association with future acute coronary syndrome and major adverse cardiovascular events | International Journal of Obesity | 2015 | 95 |
5 | Posttraumatic stress disorder, alone or additively with early life adversity, is associated with obesity and cardiometabolic risk | Nutrition, Metabolism and Cardiovascular Diseases | 2015 | 79 |
6 | Novel Noninvasive Approaches to the Treatment of Obesity: From Pharmacotherapy to Gene Therapy | Endocrine Reviews | 2022 | 39 |
7 | Pharmacotherapy of type 2 diabetes: An update and future directions | Metabolism: Clinical and Experimental | 2022 | 35 |
8 | Mechanisms underlying the cardiometabolic protective effect of walnut consumption in obese people: A cross‐over, randomized, double‐blind, controlled inpatient physiology study | Diabetes, Obesity and Metabolism | 2019 | 33 |
9 | Insulin resistance in relation to melanoma risk | Melanoma Research | 2011 | 30 |
10 | Chemerin levels as predictor of acute coronary events: A case–control study nested within the veterans affairs normative aging study | Metabolism: Clinical and Experimental | 2014 | 21 |
11 | Preserved Proinsulin Secretion in Long-Standing Type 1 Diabetes | Endocrine Practice | 2017 | 18 |
12 | Serum Adiponectin And Insulin-Like Growth Factor 1 In Predominantly Female Patients With Thyroid Cancer: Association With The Histologic Characteristics Of The Tumor | Endocrine Practice | 2016 | 16 |
13 | Beyond glycemic control: New guidance on cardio-renal protection | Metabolism: Clinical and Experimental | 2019 | 5 |